The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179, 7352-7357
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diaz-Guerra, E.
Right arrow Articles by Garcia-Sanz, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diaz-Guerra, E.
Right arrow Articles by Garcia-Sanz, J. A.

CCL2 Inhibits the Apoptosis Program Induced by Growth Factor Deprivation, Rescuing Functional T Cells1

Eva Diaz-Guerra2, Rolando Vernal2, M. Julieta del Prete2, Augusto Silva and Jose A. Garcia-Sanz3

Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain

The precise mechanisms involved in the switch between the clonal expansion and contraction phases of a CD8+ T cell response remain to be fully elucidated. One of the mechanisms implicated in the contraction phase is cytokine deprivation, which triggers apoptosis in these cells. CCR2 chemokine receptor is up-regulated following IL-2 deprivation, and its ligand CCL2 plays an essential role preventing apoptosis induced by IL-2 withdrawal not only in CTLL2 cells, but also in mouse Ag-activated primary CD8+ T cells because it rescued functional CD8+ T cells from deprivation induced apoptosis, promoting proliferation in response to subsequent addition of IL-2 or to secondary antigenic challenges. Thus, up-regulation of the CCR2 upon growth factor withdrawal together with the protective effects of CCL2, represent a double-edged survival strategy, protecting cells from apoptosis and enabling them to migrate toward sites where Ag and/or growth factors are available.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Grants SAF2003-00519 and SAF2006-04903 (to J.A.G.-S.) and SAF2006–4826 (to A.S.) from Spanish Ministry of Education and Science contracts.

2 E.D.-G., R.V., and M.J. del P. contributed equally to this work and should be considered as joint first authors.

3 Address correspondence and reprint requests to Dr. Jose A. Garcia-Sanz, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Ramiro de Maeztu 9, 28040 Madrid, Spain. E-mail address: jasanz{at}cib.csic.es

4 Abbreviation used in this paper: PI, propidium iodide.




This article has been cited by other articles:


Home page
J. Immunol.Home page
T. Wang, H. Dai, N. Wan, Y. Moore, and Z. Dai
The Role for Monocyte Chemoattractant Protein-1 in the Generation and Function of Memory CD8+ T Cells
J. Immunol., March 1, 2008; 180(5): 2886 - 2893.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.